Medical Breakthroughs
Medical Breakthroughs
Why mRNA vaccines present renewed optimism for cancer treatment
Amid the harsh reality that COVID has brought to cancer patients, there is hope coming within the oncology world through the advances in mRNA vaccines and other breakthrough therapies.
Read More
Leadership
What to expect at the upcoming Health Evolution Summit 2022
Health Evolution SVP Rob Lazerow discusses what will be different at this year’s Summit, some of the CEO-centric themes that will be addressed and the points of inspiration CEOs will gain in Laguna.
Read More
Medical Breakthroughs
TMRW Life Sciences CEO on the booming fertility services market and coming from Shake Shack
How does one go from President and CFO of Shake Shack to being the CEO of TMRW Life Sciences, a tech company in the hot fertility services market? Tara Comonte spoke with Health Evolution about her journey.
Read More
Next-Generation IT
Promising AI clinical use cases beyond imaging
The rest of clinical medicine has a way to go before catching up to imaging-based AI applications. In part two of our two-part series on clinical AI, we examine the most promising clinical areas for AI usage outside of imaging.
Read More
Next-Generation IT
AI in health care: Four challenges preventing wider clinical adoption
Health care is increasingly excited about the potential of AI to solve complex clinical and administrative problems. However, challenges with clinical workflow integration, data integrity, ethics and privacy, and ROI all remain significant barriers to increasing AI adoption.
Read More
Innovations in Care
American Health Care Cities: Rochester, Minnesota
Home to the world-famous Mayo Clinic, Rochester, Minnesota relies on health care to drive its economy more than almost any other region within the country. Google, Epic and other companies have planted a flag in Rochester and economic development leaders within the city are hoping to attract even more companies.
Read More
Next-Generation IT
Vicarious Surgical’s Adam Sachs on winning over Bill Gates, Vinod Khosla and Eric Schmidt
Vicarious Surgical went public via a special purpose acquisition company in a $1.1 billion deal and has attracted some big-name investors. CEO Adam Sachs talks with Health Evolution about how the company convinced such investors to join.
Read More
Affordability
The behavioral economics of COVID-19 vaccines
Mandates like the one President Biden put into place are effective at increasing COVID-19 vaccine rates, but they face legal challenges. Do other behavioral economics methods move the needle?
Read More
Medical Breakthroughs
Can genomics help address the cancer screening crisis?
Fewer patients are getting screened for cancer as a result of the pandemic. CancerIQ Founder & CEO Feyi Olopade Ayodele says that genomics-based screening assessments can provide health systems with a path forward to more effective cancer prevention.
Read More
Medical Breakthroughs
Eli Lilly, Takeda, Verily executives on how COVID set the stage for a new era of drug development
David Ricks, CEO of Eli Lilly, Christophe Weber, CEO of Takeda, Amy Abernethy, MD, PhD, President of Verily’s Clinical Studies Platforms, and Chris Toth, CEO of Varian, discussed how COVID has opened the door for faster drug development and improved clinical trials.
Read More
